Experts talked about the promise of gene editing and GLP-1 drugs against a backdrop of rising health care costs and funding cuts.
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback